← FDA DRUG APPROVALS

FDA ANDA · ANDA074043

PIROXICAM

Sponsor: MYLAN

APPLICATION
ANDA074043
TYPE
ANDA
ORIGINAL APPROVAL
1992-09-22
LATEST ACTION
1998-09-08
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PIROXICAMDiscontinued
PIROXICAM 10MG · CAPSULE · ORAL
PIROXICAMDiscontinued
PIROXICAM 20MG · CAPSULE · ORAL

Approval history

1998-09-08Manufacturing (CMC) · Supplement 7AP
1996-09-05Manufacturing (CMC) · Supplement 5AP
1995-10-27Manufacturing (CMC) · Supplement 6AP
1993-10-07Manufacturing (CMC) · Supplement 2AP
1993-08-12Labeling · Supplement 3AP
1993-03-24Manufacturing (CMC) · Supplement 1AP
1992-09-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →